Clinical Trials Directory

Trials / Completed

CompletedNCT01158820

Alternative Sedation During Bronchoscopy

A Randomized, Placebo-controlled, Concealed Allocation Comparison of Respiratory Depression and Coughing During Bronchoscopy With Dexmedetomidine-ketamine as an Adjunct to Fentanyl-midazolam Sedation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
50 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.

Detailed description

All patients enrolled in the study will be undergoing bronchoscopy, which is typically performed with sedation. All procedural sedation carries some risk. Several features of the study may lower the risk of sedation relative to that of conventional sedation. An anesthesiologist will be present throughout the procedure. Continuous monitoring of respiration with RIP will be employed. Administration of sedation will be via a volumetric syringe pump. Benefits specific to dexmedetomidine-ketamine include the lack of respiratory depression and greater hemodynamic stability.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidine loadDexmedetomidine 1 µg/kg prior to bronchoscopy
DRUGKetamine loadKetamine 30 mg bolus prior to bronchoscopy
DRUGMidazolam load2 mg bolus prior to bronchoscopy
DRUGFentanyl load50 µg bolus prior to bronchoscopy
DRUGDexmedetomidine maintenance0.5 µg/kg/hour for the duration of bronchoscopy (58.5 minutes average)
DRUGKetamine maintenance8 µg/kg/min for the duration of bronchoscopy (58.5 minutes average)
DRUGMidazolam demand0.5 mg demand bolus at discretion of pulmonologist
DRUGFentanyl demand12.5 µg demand bolus at discretion of pulmonologist
DRUGBenadryl demand25 mg bolus after 6th and 13th demand midazolam/fentanyl bolus

Timeline

Start date
2010-06-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2010-07-08
Last updated
2019-02-26
Results posted
2018-10-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01158820. Inclusion in this directory is not an endorsement.